PLATFORM TOO COMPLICATED?
NOT TRUSTING THE INTERPRETATION REPORTING?
RARE CANCER TYPES AND NEW VARIANTS INTERPRETATION?
WASTING TOO MUCH TIME IN BIBLIOGRAPHY SEARCH?
DATA NOT CENTRALIZED IN A UNIQUE PLACE?
REPORT NOT SUITED TO YOUR NEEDS?
OncoKDM is a web-based platform that turns your raw data into actionable clinical insight. OncoKDM is a powerful tool that addresses NGS, IHC, MSI and TMB data to provide up-to-date and accurate interpretation.
The comprehensive and interactive report includes quality control data, patient clinical data, in-depth NGS variants annotation, treatments and clinical trials options.
Add your data in a few clicks and choose your favorite technology
Create several samples based on the same technologies and parameters
Create a patient case from your uploaded data and fill in with information
AmpliSeq for Illumina BRCA Panel, AmpliSeq for Illumina Cancer Hotspot Panel V2, AmpliSeq for Illumina Comprehensive Panel V3, AmpliSeq for Illumina Focus Panel, TruSight Tumor 170, TruSight Tumor 15, TruSight Oncology 500
ClearSeq Comprehensive Cancer Panel
Human Breast cancer Panel, Human Colorectal cancer Panel, Human Lung cancer Panel, Human Actionable Solid Tumor Panel, Human BRCA1 & 2 Panel Human BRCA1 & 2 Plus Panel
OncoMINE Focus Assay, OncoMINE Comprehensive Assay, OncoMINE BRCA Assay
Any panel starting from the VCF files
What if my technology is not on the list?Challenge us
Want to make OncoKDM a fully integrated tool? Change the colors add your logo and make it personalised and tailored to your brand. Once done both interface and generated reports will be customized to your brand!
You remain the owner of the final report. Every information on which our biological and clinical interpretations are based is referenced in the report. Therefore, all data can be verified and edited to suit your needs or guidelines. You will always have the last word on the final report you want to share. Through the editing feature, you are able to modify the variant classification, the summary, the drugs choices, the clinical trials list and more, prior to your validation. The report can also be easily shared with your colleagues, following first validation by an in-house trained PhD.
Customisable clinical form Sequencing-related information Possibility to include pathology information such as H&E staining tumour sample slide
Quality control of your data including read length distribution and uniformity assessment
OncoKDM is available in 3 formulas according to your needs? Click on the most suited for you to get a personalised quotation
Address the needs
of most laboratories
Fastq or BAM
NGS, MSI, TMB, LOH, CNV
IHC Interpretation Quality Controls
We are compliant with ISO 27001:2013 (information security management systems) and ISO 13485:2016 (medical devices quality management). We are GDPR compliant. We are GCP compliant
Read length, read quality, coverage, sequencing bias, exon and/or gene mapping are all used as part our QC process.
No, OncoKDM is a somatic dedicated interpretation platform
Given the expertise of OncoDNA delivering solutions in precision medicine, we initiate this collaboration with enthusiasm to produce a specific SOLTI OncoKDM solution which will integrate the current and future molecular data types that might reveal unappreciated vulnerabilities in the tumor of AGATA patients
I'm an early user of OncoSHARE, the first reporting system developed by OncoDNA. I like the interpretation system which combines DNA and RNA sequencing, pathology, immunohistochemistries,… Now with OncoKDM, I'm very glad that our laboratory can use it to perform interpretation of our cancer data.
Comparing to competitors, OncoKDM includes patient-centric features enabling pathologists and oncologist to take the right treatment decisions according to the patient data and history. Moreover, OncoKDM is user-friendly and easy to use, one other advantage!